The role of the VNTR functional polymorphism of the promoter region of the MAOA gene on psychiatric disorders;O papel do polimorfismo funcional VNTR da região promotora do gene MAOA nos transtornos psiquiátricos

Revista de Psiquiatria Clinica

Volumn 38, Issue 1, 2011, Pages 34-42

  Nishioka, Sílvia A ^a   Perin, Eduardo Aliende ^b   Sampaio, Aline Santos ^a   Cordeiro, Quirino ^a   Cappi, Carolina ^a   Mastrorosa, Savio Rosana ^b   Morais, Ivanil A ^a   de Souza Reis, Viviane Neri ^a   do Rosário, Maria Conceição ^b   Hounie, Ana Gabriela ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Behavior; Functional polymorphism; MAOA; Monoamine oxidase; Psychiatric disorders; VNTR

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ADDICTION; AGGRESSION; ALCOHOLISM; ANOREXIA NERVOSA; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; BIPOLAR DISORDER; CONDUCT DISORDER; DEPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HEROIN DEPENDENCE; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MENTAL DISEASE; NEUROSIS; PATHOLOGICAL GAMBLING; PROMOTER REGION; PSYCHIATRY; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TOBACCO DEPENDENCE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 79955643954     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/S0101-60832011000100008     Document Type: Review

References (115)

1. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998;103(3):273-9.
2. Kirov G, Norton N, Jones I, McCandless F, Craddock N, Owen MJ. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmacol. 1999;2(4):293-8.
3. Levy ER, Powell JF, Buckle VJ, Hsu YP, Breakefield XO, Craig IW. Localization of human monoamine oxidase-A gene to Xp11.23-11.4 by in situ hybridization: implications for Norrie disease. Genomics. 1989;5(2):368-70.
4. Grimsby J, Chen K, Wang LJ, Lan NC, Shih JC. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci U S A. 1991;88(9):3637-41.
5. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, Van Gennip AH, Wolters EC, et al. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993;52(6):1032-9.
6. Brunner HG, Nelen M, Breakefield XO, Ropers HH, Van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262(5133):578-80.
7. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297(5582):851-4.
8. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999;8(4):621-4.
9. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry. 2002;7(6):626-32.
10. Das M, Bhowmik AD, Sinha S, Chattopadhyay A, Chaudhuri K, Singh M, et al. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(6):637-42.
11. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, et al. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):110-4.
12. Xu X, Brookes K, Chen CK, Huang YS, Wu YY, Asherson P. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry. 2007;7:10.
13. Lawson DC, Turic D, Langley K, Pay HM, Govan CF, Norton N, et al. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;116B(1):84-9.
14. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet. 2002;114(3):284-7.
15. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet. 2003;64(3):190-7.
16. Jones MB, Palmour RM, Zwaigenbaum L, Szatmari P. Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet B Neuropsychiatr Genet. 2004;126B(1):58-65.
17. Roohi J, DeVincent CJ, Hatchwell E, Gadow KD. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord. 2009;39(1):67-74.
18. Sand P, Lesch KP, Catalano M, Bosi M, Syagailo YV, Okladnova O, et al. Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder. World J Biol Psychiatry. 2000;1(3):147-50.
19. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A, et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004;128(1):21-6.
20. Hamilton SP, Slager SL, Heiman GA, Haghighi F, Klein DF, Hodge SE, et al. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol Psychiatry. 2000;5(5):465-6.
21. Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry. 2004;5(3):149-54.
22. Maron E, Toru I, Tasa G, Must A, Toover E, Lang A, et al. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers. Neurosci Lett. 2008;446(2-3):88-92.
23. Michelon L, Vallada H. Fatores genéticos e ambientais na manifestação do transtorno bipolar. Rev. Psiq Clín. 2005;32(Suppl 1):21-7.
24. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am J Med Genet. 1999;88(4):398-406.
25. Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M, et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry. 1999;4(4):393-5.
26. Gutiérrez B, Arias B, Gasto C, Catalan R, Papiol S, Pintor L, et al. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet. 2004;14(4):203-8.
27. Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M, Jungkunz G, et al. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet. 2001;105(2):168-71.
28. Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V, et al. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):224-8.
29. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, et al. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol. 2002;5(1):27-35.
30. Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC, Yang CW. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology. 2005;30(9):1719-23.
31. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, et al. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet. 2000;96(6):801-3.
32. Yoshida K, Naito S, Takahashi H, Sato K, Ito K, Kamata M, et al. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(7-8):1279-83.
33. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry. 2004;9(9):879-89.
34. Du L, Bakish D, Ravindran A, Hrdina PD. MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport. 2004;15(13):2097-101.
35. Cicchetti D, Rogosch FA, Sturge-Apple ML. Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: depressive symptomatology among adolescents from low socioeconomic status backgrounds. Dev Psychopathol. 2007;19(4):1161-80.
36. Kersting A, Kroker K, Horstmann J, Baune BT, Hohoff C, Mortensen LS, et al. Association of MAO-A variant with complicated grief in major depression. Neuropsychobiology. 2007;56(4):191-6.
37. Urwin RE, Bennetts BH, Wilcken B, Lampropoulos B, Beumont PJ, Russell JD, et al. Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype). Eur J Hum Genet. 2003;11(12):945-50.
38. Urwin RE, Nunn KP. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. Eur J Hum Genet. 2005;13(3):370-5.
39. Norton N, Kirov G, Zammit S, Jones G, Jones S, Owen R, et al. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet. 2002;114(5):491-6.
40. Jonsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, et al. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res. 2003;61(1):31-7.
41. Fan JB, Yang MS, Tang JX, He L, Xing YL, Shi JG, et al. Family-based association study of the functional monoamine oxidase A gene promoter polymorphism and schizophrenia. Schizophr Res. 2004;67(1):107-9.
42. Koen L, Kinnear CJ, Corfield VA, Emsley RA, Jordaan E, Keyter N, et al. Violence in male patients with schizophrenia: risk markers in a South African population. Aust N Z J Psychiatry. 2004;38(4):254-9.
43. Li D, He L. Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(2):174-8.
44. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet. 2003;120B(1):29-34.
45. Zammit S, Jones G, Jones SJ, Norton N, Sanders RD, Milham C, et al. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2004;128B(1):19-20.
46. Fresan A, Apiquian R, Garcia-Anaya M, de la Fuente-Sandoval C, Nicolini H, Graff-Guerrero A. The P50 auditory evoked potential in violent and non-violent patients with schizophrenia. Schizophr Res. 2007;97(1-3):128-36.
47. De Luca V, Tharmalingam S, Muller DJ, Wong G, De Bartolomeis A, Kennedy JL. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia. Brain Res. 2006;1097(1):26-30.
48. Matsumoto C, Shinkai T, Hori H, Ohmori O, Nakamura J. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia. Psychiatry Res. 2004;127(1-2):1-7.
49. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet B Neuropsychiatr Genet. 2003;120B(1):90-6.
50. Yu YW, Yang CW, Wu HC, Tsai SJ, Hong CJ, Chen MC, et al. Association study of a functional MAOA-mVNTR gene polymorphism and personality traits in Chinese young females. Neuropsychobiology. 2005;52(3):118-21.
51. Shiraishi H, Suzuki A, Fukasawa T, Aoshima T, Ujiie Y, Ishii G, et al. Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants. Psychiatr Genet. 2006;16(2):55-8.
52. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, et al. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatr Genet. 2000;10(2):87-90.
53. Garpenstrand H, Norton N, Damberg M, Rylander G, Forslund K, Mattila-Evenden M, et al. A regulatory monoamine oxidase a promoter polymorphism and personality traits. Neuropsychobiology. 2002;46(4):190-3.
54. Hakamata Y, Takahashi N, Ishihara R, Saito S, Ozaki N, Honjo S, et al. No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese females. Neurosci Lett. 2005;389(3):121-3.
55. Jacob CP, Muller J, Schmidt M, Hohenberger K, Gutknecht L, Reif A, et al. Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology. 2005;30(9):1711-8.
56. Urata T, Takahashi N, Hakamata Y, Iijima Y, Kuwahara N, Ozaki N, et al. Gene-gene interaction analysis of personality traits in a Japanese population using an electrochemical DNA array chip analysis. Neurosci Lett. 2007;414(3):209-12.
57. Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am J Psychiatry. 2003;160(4):671-6.
58. Manuck SB, Flory JD, Muldoon MF, Ferrell RE. Central nervous system serotonergic responsivity and aggressive disposition in men. Physiol Behav. 2002;77(4-5):705-9.
59. Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 2000;95(1):9-23.
60. Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO. ADHD and disruptive behavior scores - associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry. 2008;8:28.
61. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology. 2004;29(8):1498-505.
62. Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes HH, Kuhn J, et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry. 2004;61(7):738-44.
63. Haberstick BC, Lessem JM, Hopfer CJ, Smolen A, Ehringer MA, Timberlake D, et al. Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. Am J Med Genet B Neuropsychiatr Genet. 2005;135B(1):59-64.
64. Nilsson KW, Sjoberg RL, Damberg M, Leppert J, Ohrvik J, Alm PO, et al. Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry. 2006;59(2):121-7.
65. Young SE, Smolen A, Hewitt JK, Haberstick BC, Stallings MC, Corley RP, et al. Interaction between MAO-A genotype and maltreatment in the risk for conduct disorder: failure to confirm in adolescent patients. Am J Psychiatry. 2006;163(6):1019-25.
66. Huizinga D, Haberstick BC, Smolen A, Menard S, Young SE, Corley RP, et al. Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype. Biol Psychiatry. 2006;60(7):677-83.
67. Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig IW, et al. MAOA, maltreatment, and gene-environment interaction predicting childrens mental health: new evidence and a meta-analysis. Mol Psychiatry. 2006;11(10):903-13.
68. Passamonti L, Fera F, Magariello A, Cerasa A, Gioia MC, Muglia M, et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry. 2006;59(4):334-40.
69. Lewis A, Miller JH, Lea RA. Monoamine oxidase and tobacco dependence. Neurotoxicology. 2007;28(1):182-95.
70. Samochowiec J, Lesch KP, Rottmann M, Smolka M, Syagailo YV, Okladnova O, et al. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res. 1999;86(1):67-72.
71. Schmidt LG, Sander T, Kuhn S, Smolka M, Rommelspacher H, Samochowiec J, et al. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. J Neural Transm. 2000;107(6):681-9.
72. Contini V, Marques FZ, Garcia CE, Hutz MH, Bau CH. MAOA-mVNTR polymorphism in a Brazilian sample: further support for the association with impulsive behaviors and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(3):305-8.
73. Guindalini C, Scivoletto S, Ferreira RG, Nishimura A, Zilberman ML, Peluso MM, et al. Association of MAO A polymorphism and alcoholism in Brazilian females. Psychiatr Genet. 2005;15(2):141-4.
74. Saito T, Lachman HM, Diaz L, Hallikainen T, Kauhanen J, Salonen JT, et al. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res. 2002;109(2):113-9.
75. Lu RB, Lin WW, Lee JF, Ko HC, Shih JC. Neither antisocial personality disorder nor antisocial alcoholism is associated with the MAO-A gene in Han Chinese males. Alcohol Clin Exp Res. 2003;27(6):889-93.
76. Parsian A, Cloninger CR, Sinha R, Zhang ZH. Functional variation in promoter region of monoamine oxidase A and subtypes of alcoholism: haplotype analysis. Am J Med Genet B Neuropsychiatr Genet. 2003;117B(1):46-50.
77. Lu RB, Lee JF, Ko HC, Lin WW, Chen K, Shih JC. No association of the MAOA gene with alcoholism among Han Chinese males in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(3):457-61.
78. Koller G, Bondy B, Preuss UW, Bottlender M, Soyka M. No association between a polymorphism in the promoter region of the MAOA gene with antisocial personality traits in alcoholics. Alcohol Alcohol. 2003;38(1):31-4.
79. Ducci F, Enoch MA, Hodgkinson C, Xu K, Catena M, Robin RW, et al. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry. 2008;13(3):334-47.
80. Nilsson KW, Sjoberg RL, Wargelius HL, Leppert J, Lindstrom L, Oreland L. The monoamine oxidase A (MAO-A) gene, family function and maltreatment as predictors of destructive behaviour during male adolescent alcohol consumption. Addiction. 2007;102(3):389-98.
81. Nilsson KW, Wargelius HL, Sjoberg RL, Leppert J, Oreland L. The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour. Drug Alcohol Depend. 2008;93(1-2):51-62.
82. Sjoberg RL, Ducci F, Barr CS, Newman TK, Dellosso L, Virkkunen M, et al. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology. 2008;33(2):425-30.
83. Herman AI, Kaiss KM, Ma R, Philbeck JW, Hasan A, Dasti H, et al. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiatr Genet. 2005;133B(1):74-8.
84. Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, Wang TJ, et al. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci. 2007;32(3):185-92.
85. Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, et al. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):108-14.
86. Ito H, Hamajima N, Matsuo K, Okuma K, Sato S, Ueda R, et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics. 2003;13(2):73-9.
87. Jin Y, Chen D, Hu Y, Guo S, Sun H, Lu A, et al. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. Int J Neuropsychopharmacol. 2006;9(5):557-64.
88. Wiesbeck GA, Wodarz N, Weijers HG, Dursteler-MacFarland KM, Wurst FM, Walter M, et al. A functional polymorphism in the promoter region of the monoamine oxidase A gene is associated with the cigarette smoking quantity in alcohol-dependent heavy smokers. Neuropsychobiology. 2006;53(4):181-5.
89. Gerra G, Garofano L, Santoro G, Bosari S, Pellegrini C, Zaimovic A, et al. Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am J Med Genet B Neuropsychiatr Genet. 2004;126B(1):37-42.
90. Corless T, Dickerson M. Gamblers self-perceptions of the determinants of impaired control. Br J Addict. 1989;84(12):1527-37.
91. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J. Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO-A and the 5-HT transporter genes. Mol Psychiatry. 2002;7(9):927-8.
92. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4(10):819-28.
93. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport. 2002;13(9):1195-8.
94. Sherif F, Marcusson J, Oreland L. Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci. 1991;241(3):139-44.
95. Mann JJ, Stanley M. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand. 1984;69(2):135-9.
96. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, et al. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet. 2002;114(3):340-2.
97. Courtet P, Jollant F, Buresi C, Castelnau D, Mouthon D, Malafosse A. The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet. 2005;15(3):189-93.
98. De Luca V, Tharmaligam S, Strauss J, Kennedy JL. 5-ht2c receptor and MAO-A interaction analysis: no association with suicidal behaviour in bipolar patients. Eur Arch Psychiatry Clin Neurosci. 2008;258(7):428-33.
99. Díaz-Anzaldúa A, Joober R, Riviere JB, Dion Y, Lesperance P, Richer F, et al. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol Psychiatry. 2004;9(3):272-7.
100. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006;15(21):3132-45.
101. Abdolmaleky HM, Thiagalingam S, Wilcox M. Genetics and epigenetics in major psychiatric disorders - Dilemmas, achievements, applications, and future scope. Am J Pharmacogenomics. [Review]. 2005;5(3):149-60.
102. Turecki G. Dissecting the suicide phenotype: the role of impulsive- -aggressive behaviours. J Psychiatry Neurosci. 2005;30(6):398-408.
103. Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005;162(11):2116-24.
104. Altshuler D, Daly M, Kruglyak L. Guilt by association. Nat Genet. 2000;26(2):135-7.
105. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, et al. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet. 2000;96(6):858-60.
106. Ojopi E, Gregorio S, Guimarães P, Fridman C, Dias Neto E. O genoma humano e as perspectivas para o estudo da esquizofrenia. Rev Psiquiatr Clín. 2004;31(1):9-18.
107. Craddock N, Daniels J, Roberts E, Rees M, McGuffin P, Owen MJ. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am J Med Genet. 1995;60(4):322-4.
108. Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am J Med Genet. 2002;114(4):380-90.
109. Huang SY, Lin MT, Shy MJ, Lin WW, Lin FY, Lu RB. Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2008;258(6):350-6.
110. Kawada Y, Hattori M, Dai XY, Nanko S. Possible association between monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet. 1995;56(1):335-6.
111. Lim LC, Powell J, Sham P, Castle D, Hunt N, Murray R, et al. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am J Med Genet. 1995;60(4):325-31.
112. Lin S, Jiang S, Wu X, Qian Y, Wang D, Tang G, et al. Association analysis between mood disorder and monoamine oxidase gene. Am J Med Genet. 2000;96(1):12-4.
113. Lin YM, Davamani F, Yang WC, Lai TJ, Sun HS. Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese. Behav Brain Funct. 2008;4:21.
114. Muller DJ, Serretti A, Sicard T, Tharmalingam S, King N, Artioli P, et al. Further evidence of MAO-A gene variants associated with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(1):37-40.
115. Muramatsu T, Matsushita S, Kanba S, Higuchi S, Manki H, Suzuki E, et al. Monoamine oxidase genes polymorphisms and mood disorder. Am J Med Genet. 1997;74(5):494-6.